Live Breaking News & Updates on Jonathan javitt

Stay informed with the latest breaking news from Jonathan javitt on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jonathan javitt and stay connected to the pulse of your community

NRx Pharmaceuticals Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

RADNOR - NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that the Company has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar...

Massachusetts , United-states , France , French , Jonathan-javitt , Matthew-duffy , Andrew-nierenberg , Jeremy-feffer , Exchange-commission , Nasdaq , Lotus-pharmaceuticals-inc , Lotus

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Jonathan-javitt , Andrew-nierenberg , Nrx-pharmaceuticals , Alvogen-inc , Nrx-pharmaceuticals-inc , Nasdaq , Nrxp-nrx-pharmaceuticals , Lotus-pharmaceuticals-inc , Treatment-resistant-bipolar-depression-study , Lotus-pharmaceuticals

NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...

France , French , Jonathan-javitt , Us-national-institutes-of-health , Nasdaq , Prnewswire-nrx-pharmaceuticals-inc , Nrxp-nrx-pharmaceuticals , Lotus , Nrx-pharmaceuticals , Continental-stock-transfer-trust-company , Common-stock-will-begin-trading , Split-adjusted-basis

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK -March 25, 2024 at 08:31 am EDT

RADNOR, Pa., March 25, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx...

France , Radnor , Powys , United-kingdom , French , Jonathan-javitt , Nasdaq , Us-national-institutes-of-health , Prnewswire-nrx-pharmaceuticals-inc , Source-nrx-pharmaceuticals-inc , Specialty-pharmaceutical-company , Therapeutics-inc

NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million

In the news release, NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock, issued 27-Feb-2024 by NRx Pharmaceuticals, Inc. over PR Newswire, we...

France , New-york , United-states , French , Jonathan-javitt , Therapeutics-inc , Lotus , Securities-exchange , Syndicate-department , Company-chairman , Us-national-institutes-of-health , Exchange-commission

NRx Pharmaceuticals (NRXP) Prices $1.5M Share Offering at $0.30/sh

NRx Pharmaceuticals (NRXP) Prices $1.5M Share Offering at $0.30/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Jonathan-javitt , Nrx-pharmaceuticals-inc , Syndicate-department , Ef-hutton , Nasdaq , Exchange-commission , Nrx-pharmaceuticals , Company-chairman ,

NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024 -February 26, 2024 at 08:31 am EST

Presentation available on NRx Pharmaceuticals website at https://www.nrxpharma.com/hope-therapeutics/KEY UPDATES ARE AS FOLLOWS:
NRx management is proposing to award 50% of founding shares in HOPE...

France , New-york , United-states , French , Marriot-marquis , Matthew-duffy , Jonathan-javitt , Us-national-institutes-of-health , Therapeutics-inc , Source-nrx-pharmaceuticals-inc , Nrx-pharmaceuticals , Lotus

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon -February 05, 2024 at 06:49 am EST

HOPE Therapeutics is dedicated to bringing NRX-100 for Suicidal Depression to patientsCompany to be initially owned by NRx and current NRx shareholders via a planned tax-free dividendA New Drug...

France , United-states , French , Jonathan-javitt , Prnewswire-nrx-pharmaceuticals-inc , Nrxp-nrx-pharmaceuticals , Nrx-pharmaceuticals-inc , Source-nrx-pharmaceuticals-inc , Us-national-institutes-of-health , Nasdaq , Alvogen-pharmaceuticals , Nrx-pharmaceuticals

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France , United-states , French , Jonathan-javitt , Us-national-institutes-of-health , Source-nrx-pharmaceuticals-inc , Nrxp-nrx-pharmaceuticals , Nrx-pharmaceuticals-inc , Prnewswire-nrx-pharmaceuticals-inc , Nrx-pharmaceuticals , Alvogen-pharmaceuticals , Nasdaq

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression -January 22, 2024 at 06:49 am EST

Exceeded originally target enrollment with n=74 Last patient, last visit expected in approximately six weeks; data to follow shortly thereafterPositive...

Massachusetts , United-states , France , French , Andrew-nierenberg , Jonathan-javitt , Nasdaq , Alvogen-pharmaceuticals , Prnewswire-nrx-pharmaceuticals-inc , Nrxp-nrx-pharmaceuticals , Us-national-institutes-of-health , Nrx-pharmaceuticals-inc